ADC Therapeutics's total assets for Q4 2025 were $323.15M, an increase of 11.52% from the previous quarter. ADCT total liabilities were $508.98M for the fiscal quarter, a -3.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.